Cardiac amyloidosis in a patient with multiple myeloma
DOI:
https://doi.org/10.51481/amc.v61i3.1041Keywords:
Cardiac Amyloidosis, Primary Amyloidosis, Infiltrative Cardiomyopathy, Heart FailureAbstract
Systemic amyloidosis constitutes a non common disease in which cardiac involvement is the leading cause of morbidity and mortality, regardless of the underlying pathogenesis of amyloid production. We present the case of a 48 years old female with nephrotic syndrome, heart failure and immunocompromise in which Primary Amyloidosis with cardiac involvement secondary to Multiple Myeloma is established as diagnosis. The disease is briefly discussed, as well as the value of clinical judgment supported on diagnostic means and the therapeutic challenges now days.
Downloads
References
Maron BJ, Towbin JA, Thiene G, Antzelevith C, Corrado D, Arnett D, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association scientific statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Group; and Council on Epidemiology and Prevention. Circulation. 2006; 113:1807-1816.
García-Pavía P, Tomé-Esteban MT, Rapezzi C. [Amiloidosis, also an illness of the heart]. Rev Esp Cardio. 2011;64:797-808. Spanish.
Pinney JH, Smith CJ, Taube JB, Lachmann HJ, Venner CP, Gibbs SD, et al. Systemic amyloidosis in England: an epidemiological study. Br J Haematol. 2013;161(4):525-532.
Martínez- Naharro A, Hawkins PN, Fontana M. Cardiac amyloidosis. Clin Med. 2018;18,2:S30-S5.
González López E, López Sainz, García Pavia P. Diagnosis and treatment of transthyretin
amyloidosis. progress and hope. Rev Esp Cardio. 2017;70(11):991-1004. Spanish.
Downloads
Published
Versions
- 2019-08-29 (2)
- 2019-08-29 (1)
Issue
Section
License
Copyright (c) 2019 Acta Médica Costarricense
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)
